Kyndryl Announces Collaboration with Microsoft to Enable AI-powered Healthcare
Kyndryl Announces Collaboration with Microsoft to Enable AI-powered Healthcare |
[03-March-2025] |
Kyndryl Collaborates with Microsoft to Bring Dragon Copilot to Market Dragon Copilot to be enabled by generative AI-powered ambient listening voice recognition NEW YORK, March 3, 2025 /PRNewswire/ -- Kyndryl (NYSE: KD), the world's largest IT infrastructure services provider, today announced it is partnering with Microsoft to support adoption and deployment of a new AI-powered healthcare assistant. Kyndryl will collaborate with Microsoft as a strategic partner for the new Microsoft Dragon Copilot solution that will use voice dictation, ambient listening, and natural language capabilities powered by generative AI to automate clinical documentation, improve administrative efficiency and allow clinicians to focus on patient care. Kyndryl will support customer adoption of Dragon Copilot by providing services to enable:
"Today's announcement marks a significant milestone in Kyndryl's commitment to optimizing clinical workflows and improving patient care by deploying mission-critical AI technology," said Trent Sanders, Vice President for U.S. Healthcare and Life Sciences at Kyndryl. "We're thrilled to be a Microsoft launch partner as we work to address clinician burnout and improve the overall healthcare experience. By automating routine tasks to unlock insights, we can empower and help clinicians reclaim valuable time to spend with their patients." "With their vast experience in healthcare IT services, Kyndryl has been selected as a launch partner for Dragon Copilot. Kyndryl understands patient care and supports large and small healthcare providers and payers globally. Kyndryl's services capability combined with Microsoft's AI-enabled solutions will deliver innovative solutions that improve patient and member experiences while optimizing healthcare operations," said Patty Carrolo, CVP Microsoft US Health and Life Sciences. Kyndryl plans to offer Dragon Copilot as a key solution in its healthcare services portfolio beginning in May 2025. Kyndryl's team of experts will provide comprehensive support and implementation services, to support healthcare organizations seamlessly integrate Dragon Copilot into their existing workflows. For more information about Kyndryl's healthcare solutions and to connect with a healthcare expert, please book a consultation here. About Kyndryl Forward-looking statements This press release contains "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. Such forward-looking statements often contain words such as "aim," "anticipate," "believe," "contemplate," "could," "estimate," "expect," "forecast," "intend," "may," "objectives," "opportunity," "plan," "position," "predict," "project," "should," "seek," "target," "will," "would" and other similar words or expressions or the negative thereof or other variations thereon. All statements other than statements of historical fact, including without limitation statements concerning the Company's plans, objectives, goals, beliefs, business strategies, future events, business condition, results of operations, financial position, business outlook and business trends and other non-historical statements, are forward-looking statements. These statements do not guarantee future performance and speak only as of the date of this press release. Except as required by law, the Company assumes no obligations to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise. Actual outcomes or results may differ materially from those suggested by forward-looking statements as a result of risks and uncertainties including those described in the "Risk Factors" section of the Company's most recent Annual Report on Form 10-K, and may be further updated from time to time in the Company's subsequent filings with the Securities and Exchange Commission. Kyndryl Press Contact
SOURCE Kyndryl | ||
Company Codes: NYSE:KD |